DE1356491U - - Google Patents

Info

Publication number
DE1356491U
DE1356491U DENDAT1356491D DE1356491DU DE1356491U DE 1356491 U DE1356491 U DE 1356491U DE NDAT1356491 D DENDAT1356491 D DE NDAT1356491D DE 1356491D U DE1356491D U DE 1356491DU DE 1356491 U DE1356491 U DE 1356491U
Authority
DE
Germany
Prior art keywords
tor
int
tnt
den
eats
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1356491D
Other languages
German (de)
English (en)
Publication of DE1356491U publication Critical patent/DE1356491U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1356491D Active DE1356491U (enExample)

Publications (1)

Publication Number Publication Date
DE1356491U true DE1356491U (enExample)

Family

ID=670792

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1356491D Active DE1356491U (enExample)

Country Status (1)

Country Link
DE (1) DE1356491U (enExample)

Similar Documents

Publication Publication Date Title
Tsuruo et al. 4′-O-tetrahydropyranyladriamycin as a potential new antitumor agent
Tsuda et al. Analysis of N‐myc amplification in relation to disease stage and histologic types in human neuroblastomas
DE69334158T2 (de) Monoklonale Antikörper gegen den Interferonrezeptor, mit neutralisierender Aktivität gegen Typ I-Interferon
Hahn et al. Repair of potentially lethal damage in vivo in solid tumor cells after X-irradiation
DE60020469T2 (de) Propylenharzzusammensetzung und verfahren zu deren herstellung
Bataille et al. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma
EP1340483B1 (de) Dentalmaterialien auf der Basis von (Meth)acrylatsubstuierten Iminooxadiazindion-Derivaten
Mutch et al. In vitro analysis of the anticancer potential of tumor necrosis factor in combination with cisplatin
US6217858B1 (en) Pharmaceutical composition for treating hepatitis B virus (HBV) infection
DE1570919B2 (de) Verfahren zur Herstellung von Horao- oder Mischpolymerisaten des Propylens. °
Lagadec et al. Human small‐cell lung‐cancer cells are cytokine‐resistant but NK/LAK‐sensitive
Kao et al. Immunomodulation of Bu-Zhong-Yi-Qi-Tang on In Vitro Granulocyte Colony-Stimulating-Factor and Tumor Necrosis Factor-α Production by Peripheral Blood Mononuclear Cells
Shimkin et al. Trisethylene-imino-s-triazine (triethylene melamine or TEM) in the treatment of neoplastic diseases
DE1188279B (de) Verbesserung der Zaehigkeit von Polypropylen
Sayers et al. Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
DE1233134B (de) Gegen Licht und Waermeeinfluss durch Metallsalze von Dithiophosphorverbindungen stabilisierte Formmassen aus Polyolefinen
Shepherd et al. Severe cytopenias associated with the sequential use of busulphan and interferon‐alpha in chronic myeloid leukaemia
DE3884300T2 (de) Magnetische Polymerzusammensetzungen.
DE3874142T2 (de) Pharmazeutische zusammensetzung mit antikrebswirkung und methode fuer die behandlung von krebs.
SPInTZYK et al. Additive Fertigung bei 3D-gedruckten Alignern.
TWI547286B (zh) 趨化激素受體拮抗劑及其組合療法
HONG et al. Colony Inhibitory Effect of Recombinant Human Tumor Necrosis Factor (rH-TNF) and/or Recombinant Human Interferon (rH-IFN)-α-β and-γ on Human Lung Cancer Cell Lines
Kleeberg et al. Phase II study of pirarubicin in metastatic breast cancer
Berlangieri et al. Distribution of 99Tcm-sulphur colloid during granulocyte colony-stimulating factor administration in autologous bone marrow transplantation
Kakumu et al. Effects of transforming growth factor‐β1 against the inhibitory action of interferon on DNA synthesis and viral replication in hepatitis B virus DNA‐transfected cell